Cantor Fitzgerald Downgrades ADMA Biologics (ADMA) to Neutral

March 26, 2026 3:46 AM

Cantor Fitzgerald analyst Kristen Kluska downgraded ADMA Biologics (NASDAQ: ADMA) from Overweight to Neutral.The analyst comments: "Following ADMA shares trading ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found